MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Conduritol B epoxide

CAS No. : 6090-95-5

MCE 国际站：Conduritol B epoxide

产品活性：Conduritol B epoxide 是一种不可逆的，共价的 β-glucosidase 抑制剂。

研究领域：Metabolic Enzyme/Protease

作用靶点：Glucosidase

In Vitro: Treating N2a and Conduritol B epoxide-N2a cells with G6 gave GC reductions to 7% and 26% of untreated levels, respectively. G6 treated Conduritol B epoxide-N2a also has significantly decreased GS. Co-treatment of G6 and dantrolene of Conduritol B epoxide-N2a cells lead to a similar degree of GC and GS reduction as G6 alone, indicating a specific effect of G6 on inhibition of substrate accumulation, Conduritol B epoxide-N2a cells have higher calcium levels than in N2a cells without caffeine at baseline. Conduritol B epoxide-N2a cells show a significant increase in cytosolic calcium levels compared to N2a cells. Conduritol B epoxide-N2a cells show a significant reduction in OCR as evidenced by approximately 50% in all the parameters, including rate of ATP production, basal respiration, and maximal respiration, compared to N2a cells, indicating reduced mitochondrial function in this nGD cell model. In dantrolene-treated Conduritol B epoxide-N2a cells, levels of Ryr3 are increased to 76% of WT level.

In Vivo: Conduritol B epoxide treatment of 4L, 9H, 9V and WT mice (100 mg/kg/day, i.p.) from postnatal day 5 to 11 does not induce α-synuclein aggregates. Long-term daily Conduritol B epoxide treatment of 4L mice (100 mg/kg/day of Conduritol B epoxide from postnatal day 15 for 24 or 36 doses) leads to hind limb paralysis and small amounts of α-synuclein accumulation in the olfactory bulb, brainstem, and PVP near D3V (dorsal 3rd ventricle).

相关产品：Covalent Screening Library Plus  |  Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Covalent Screening Library  |  Glycoside Compound Library  |  Anti-Obesity Compound Library  |  Glucose Metabolism Compound Library  |  Targeted Diversity Library  |  Acarbose  |  Castanospermine  |  1-Deoxynojirimycin  |  Fucoidan  |  Ambroxol  |  3,4-Dicaffeoylquinic acid  |  Naringinase  |  Gcase activator 1  |  Celgosivir hydrochloride  |  NCGC00092410  |  Oroxin A  |  Rebaudioside A  |  Hexylresorcinol  |  (+)-Afzelechin  |  Brevifolincarboxylic acid  |  Kaempferol-7-O-rhamnoside  |  Voglibose  |  4',5-Dihydroxyflavone  |  Cedryl acetate  |  Licochalcone C  |  Afegostat D-Tartrate  |  Ganoderic acid Y  |  IHVR-19029  |  Kushenol A  |  N-Nonyldeoxynojirimycin  |  Panasenoside  |  Terphenyllin  |  β-Hydroxypropiovanillone

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物  |  寡核苷酸

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种TOP期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪前沿的制药及生命科学研究进展，为您提供全球前沿的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。